A Direct-to Patient Methodology to Rejuvenate the Biopharma Space

ixlayer, a healthcare technology platform serving biopharma, has officially announced the launch of ixEngage, which happens to be a direct-to-patient solution. According to certain reports, the stated technology brings forth compliant infrastructure to connect biopharma clients to the full healthcare ecosystem i.e. labs, patients, payments, providers, and prescriptions. This it effectively does to deploy personalized, patient customer experience (Cx) programs that meet the highest industry safety standards. More on the same would reveal how ixEngage accelerates a patient’s path to diagnosis in moving lab testing further up the patient journey, while simultaneously making it more convenient and accessible for them to connect with their physicians, Furthermore, it comes bearing an ability to integrate into biopharma’s disease state awareness (DSA), educational and marketing campaigns for existing or new go-to-market strategies, thus helping traditional campaigns become more actionable and effective.

Talk about the new solution on a slightly deeper level, it begins with the promise of a virtual patient experience, an experience where ixEngage manages for you the whole of clinical onboarding, patient intake and consents proceedings. Beyond that, it facilities secure lab result delivery, ongoing communication, and connection to care. We referred to how the solution is well-equipped in the context of conducting a secure lab delivery, but we haven’t yet touched upon the fact that it can also handle multimodal lab testing. This translates to the way ixEngage ensures optimal patient choice and configurability to meet clients’ needs. Covering turnkey self-collection kits (for saliva, blood, urine or fecal samples), it banks upon CLIA-certified and CAP-accredited labs. Not just that, the solution is also understood to offer mobile phlebotomy and patient service center options.

Then, there is a facility dedicated towards telehealth and connected care. Here, ixEngage implements telehealth services and clinical oversight across the patient’s journey. An example relaying the same is rooted in its bid to provide lab results through a private online portal, aided by ixlayer’s network of telehealth partners.

“We believe the future of biopharma success will hinge on more proactive, data-driven collaboration with patients,” said Pouria Sanae, CEO and Co-founder of ixlayer. “Developing a comprehensive, direct-to-patient program demands intricate logistics, often costing millions and years to establish. With ixEngage, pharmaceutical companies can expedite this process, strengthen marketing campaigns, link patients with essential medical care and pave the path for future success and improved patient outcomes.”

Moving on, ixEngage also has the means to fulfill prescription obligations. As for how it does that, the solution leverages e-prescribing, specialty medication dispensing and home delivery with online updates, as well as patient notifications. Joining the mix would be an assortment of finance, payments, and insurance-focused features. These features, at launch, are likely to be concerned with areas like benefits verification, claims submission, and online patient payment options, each one meticulously designed to help patients navigate the complexities of healthcare payment – out of pocket and through insurance. Rounding up highlights is a functionality built around analytics. The stated functionality makes it possible for partners to access in-depth analytics and gain performance tracking, along with campaign insights.

Founded in, ixlayer’s rise up the ranks stems from being a leading provider of cloud-based platforms that power a seamless, end-to-end direct-to-patient healthcare experience. At present, the company is supplying solutions capable accelerating the path to diagnoses, support optimal care, drive operational efficiency, and improve health equity and outcomes for all. ixlayer’s excellence in what it does can also be inferred once you take into account how it has, till date, activated over four million patient care journeys across more than 1,100 programs.

• By Editorial Panel
• 22 Mar 2025